{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:24:07Z","timestamp":1787703847215,"version":"build-2784847793"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75509-4","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:07:28Z","timestamp":1784801248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinspired porous metal-amino acid nanozymes enable multi-pathway treatment of atherosclerosis through anti-oxidation and pro-efferocytosis"],"prefix":"10.1038","volume":"17","author":[{"given":"Sihui","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1437-4308","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-3325","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-5360","authenticated-orcid":false,"given":"Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"75509_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132 (2024).","journal-title":"Lancet"},{"key":"75509_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren, J. L. M. & Lusis, A. J. Atherosclerosis: recent developments. Cell 185, 1630\u20131645 (2022).","journal-title":"Cell"},{"key":"75509_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"75509_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann, U., Xia, N. & Li, H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ. Res. 120, 713\u2013735 (2017).","journal-title":"Circ. Res."},{"key":"75509_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein, O. & Libby, P. Targeting inflammation in atherosclerosis-from experimental insights to the clinic. Nat. Rev. Drug. Discov. 20, 589\u2013610 (2021).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"75509_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr.","year":"2016","unstructured":"Gimbrone, M. A. Jr. & Garc\u00eda-Carde\u00f1a, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118, 620\u2013636 (2016).","journal-title":"Circ. Res."},{"key":"75509_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck, M., Yurdagul, A. Jr., Tabas, I., \u00d6\u00f6rni, K. & Kovanen, P. T. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat. Rev. Cardiol. 16, 389\u2013406 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"75509_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen, S. E., Robinson, A. J. B., Zurke, Y. X. & Monaco, C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat. Rev. Cardiol. 19, 522\u2013542 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"75509_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"New Engl. J. Med."},{"key":"75509_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","volume":"12","author":"M B\u00e4ck","year":"2015","unstructured":"B\u00e4ck, M. & Hansson, G. K. Anti-inflammatory therapies for atherosclerosis. Nat. Rev. Cardiol. 12, 199\u2013211 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"75509_CR11","doi-asserted-by":"publisher","first-page":"106157","DOI":"10.1016\/j.phrs.2022.106157","volume":"178","author":"A Hafiane","year":"2022","unstructured":"Hafiane, A. & Daskalopoulou, S. S. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Pharmacol. Res. 178, 106157 (2022).","journal-title":"Pharmacol. Res."},{"key":"75509_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima, Y., Weissman, I. L. & Leeper, N. J. The role of efferocytosis in atherosclerosis. Circulation 135, 476\u2013489 (2017).","journal-title":"Circulation"},{"key":"75509_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41569-024-01037-7","volume":"21","author":"SS Adkar","year":"2024","unstructured":"Adkar, S. S. & Leeper, N. J. Efferocytosis in atherosclerosis. Nat. Rev. Cardiol. 21, 762\u2013779 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"75509_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg, M. E. W., Scheeren, F. A. & Schumacher, T. N. The CD47-SIRP\u03b1 immune checkpoint. Immunity 52, 742\u2013752 (2020).","journal-title":"Immunity"},{"key":"75509_CR15","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1093\/cvr\/cvab369","volume":"118","author":"B Singla","year":"2022","unstructured":"Singla, B. et al. Loss of myeloid cell-specific SIRP\u03b1, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovasc. Res. 118, 3097\u20133111 (2022).","journal-title":"Cardiovasc. Res."},{"key":"75509_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay, A. N. & Van den Berg, T. K. The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target. Annu. Rev. Immunol. 32, 25\u201350 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"75509_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016).","journal-title":"Nature"},{"key":"75509_CR18","first-page":"5418","volume":"18","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Multipathway regulation for targeted atherosclerosis therapy using anti-miR-33-loaded DNA origami. ACS Nano 18, 5418\u20135433 (2024).","journal-title":"ACS Nano"},{"key":"75509_CR19","doi-asserted-by":"publisher","first-page":"8943","DOI":"10.1021\/acsnano.8b02037","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano 12, 8943\u20138960 (2018).","journal-title":"ACS Nano"},{"key":"75509_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307441","volume":"11","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Target functionalized carbon dot nanozymes with dual-model photoacoustic and fluorescence imaging for visual therapy in atherosclerosis. Adv. Sci. 11, e2307441 (2024).","journal-title":"Adv. Sci."},{"key":"75509_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41565-024-01687-1","volume":"19","author":"Z He","year":"2024","unstructured":"He, Z. et al. Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment. Nat. Nanotechnol. 19, 1386\u20131398 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"75509_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34248-y","volume":"13","author":"X Fu","year":"2022","unstructured":"Fu, X. et al. Small molecule-assisted assembly of multifunctional ceria nanozymes for synergistic treatment of atherosclerosis. Nat. Commun. 13, 6528 (2022).","journal-title":"Nat. Commun."},{"key":"75509_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2022.06.008","volume":"34","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Enhanced macrophage polarization induced by COX-2 inhibitor-loaded Pd octahedral nanozymes for treatment of atherosclerosis. Chin. Chem. Lett. 34, 107585 (2023).","journal-title":"Chin. Chem. Lett."},{"key":"75509_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309062","volume":"11","author":"F Lv","year":"2024","unstructured":"Lv, F. et al. Curcumin equipped nanozyme-like metal-organic framework platform for the targeted atherosclerosis treatment with lipid regulation and enhanced magnetic resonance imaging capability. Adv. Sci. 11, e2309062 (2024).","journal-title":"Adv. Sci."},{"key":"75509_CR25","doi-asserted-by":"publisher","first-page":"15959","DOI":"10.1021\/acsnano.2c03422","volume":"16","author":"R Hu","year":"2022","unstructured":"Hu, R. et al. Living macrophage-delivered tetrapod PdH nanoenzyme for targeted atherosclerosis management by ROS scavenging, hydrogen anti-inflammation, and autophagy activation. ACS Nano 16, 15959\u201315976 (2022).","journal-title":"ACS Nano"},{"key":"75509_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304465","volume":"62","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. Integrated cascade nanozymes with antisenescence activities for atherosclerosis therapy. Angew. Chem. Int. Ed. 62, e202304465 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75509_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202401361","volume":"36","author":"C Ding","year":"2024","unstructured":"Ding, C. et al. Combating atherosclerosis with chirality\/phase dual-engineered nanozyme featuring microenvironment-programmed senolytic and senomorphic actions. Adv. Mater. 36, e2401361 (2024).","journal-title":"Adv. Mater."},{"key":"75509_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202313646","volume":"34","author":"C Dai","year":"2024","unstructured":"Dai, C. et al. Mesoporous ternary nanozymes with anti-senescence and anti-inflammation activities for atherosclerosis management. Adv. Funct. Mater. 34, 2313646 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"75509_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccr.2017.01.001","volume":"336","author":"Y-W Lin","year":"2017","unstructured":"Lin, Y.-W. Rational design of metalloenzymes: from single to multiple active sites. Coord. Chem. Rev. 336, 1\u201327 (2017).","journal-title":"Coord. Chem. Rev."},{"key":"75509_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2021.101295","volume":"41","author":"J Han","year":"2021","unstructured":"Han, J., Gong, H., Ren, X. & Yan, X. Supramolecular nanozymes based on peptide self-assembly for biomimetic catalysis. Nano Today 41, 101295 (2021).","journal-title":"Nano Today"},{"key":"75509_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2023.01.068","volume":"355","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Guo, F., Hou, L., Zhao, Y. & Sun, P. Electron transfer-based antioxidant nanozymes: emerging therapeutics for inflammatory diseases. J. Control. Release 355, 273\u2013291 (2023).","journal-title":"J. Control. Release"},{"key":"75509_CR32","doi-asserted-by":"publisher","first-page":"2211147","DOI":"10.1002\/adma.202211147","volume":"36","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Wang, H. & Qu, X. Biosystem-inspired engineering of nanozymes for biomedical applications. Adv. Mater. 36, 2211147 (2024).","journal-title":"Adv. Mater."},{"key":"75509_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41591-1","volume":"14","author":"Y Yuan","year":"2023","unstructured":"Yuan, Y. et al. Histidine modulates amyloid-like assembly of peptide nanomaterials and confers enzyme-like activity. Nat. Commun. 14, 5808 (2023).","journal-title":"Nat. Commun."},{"key":"75509_CR34","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1039\/C6NR09810J","volume":"9","author":"K Korschelt","year":"2017","unstructured":"Korschelt, K. et al. Glycine-functionalized copper(ii) hydroxide nanoparticles with high intrinsic superoxide dismutase activity. Nanoscale 9, 3952\u20133960 (2017).","journal-title":"Nanoscale"},{"key":"75509_CR35","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1021\/nn302789r","volume":"6","author":"IE Rauda","year":"2012","unstructured":"Rauda, I. E. et al. General method for the synthesis of hierarchical nanocrystal-based mesoporous materials. ACS Nano 6, 6386\u20136399 (2012).","journal-title":"ACS Nano"},{"key":"75509_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16439-7","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).","journal-title":"Nat. Commun."},{"key":"75509_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202319876","volume":"63","author":"R Gao","year":"2024","unstructured":"Gao, R. et al. Ionic liquid-mediated dynamic polymerization for facile aqueous-phase synthesis of enzyme-covalent organic framework biocatalysts. Angew. Chem. Int. Ed. 63, e202319876 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75509_CR38","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1039\/C5CS00234F","volume":"44","author":"R Zou","year":"2015","unstructured":"Zou, R. et al. Peptide self-assembly triggered by metal ions. Chem. Soc. Rev. 44, 5200\u20135219 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"75509_CR39","doi-asserted-by":"publisher","first-page":"1909614","DOI":"10.1002\/adfm.201909614","volume":"30","author":"K Tao","year":"2020","unstructured":"Tao, K. et al. Enhanced fluorescence for bioassembly by environment-switching doping of metal ions. Adv. Funct. Mater. 30, 1909614 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"75509_CR40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/chem.201704032","volume":"24","author":"Q Zou","year":"2018","unstructured":"Zou, Q. & Yan, X. Amino acid coordinated self-assembly. Chem. Eur. J. 24, 755\u2013761 (2018).","journal-title":"Chem. Eur. J."},{"key":"75509_CR41","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1139\/v87-417","volume":"65","author":"EA Secco","year":"1987","unstructured":"Secco, E. A. & Worth, G. G. Infrared spectra of unannealed and of annealed Cu4(OH)6(NO3)2. Can. J. Chem. 65, 2504\u20132508 (1987).","journal-title":"Can. J. Chem."},{"key":"75509_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0584-8539(76)80078-5","volume":"32","author":"JR Kincaid","year":"1976","unstructured":"Kincaid, J. R. & Nakamoto, K. Vibrational spectra and normal coordinate analysis of bis(glycino) complexes with Ni(II), Cu(II) and Co(II). Spectrochim. Acta Part A 32, 277\u2013283 (1976).","journal-title":"Spectrochim. Acta Part A"},{"key":"75509_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11157-1","volume":"10","author":"WL Liu","year":"2019","unstructured":"Liu, W. L. et al. Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells. Nat. Commun. 10, 3199 (2019).","journal-title":"Nat. Commun."},{"key":"75509_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46436-z","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. et al. Acidity-activatable upconversion afterglow luminescence cocktail nanoparticles for ultrasensitive in vivo imaging. Nat. Commun. 15, 2124 (2024).","journal-title":"Nat. Commun."},{"key":"75509_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122907","volume":"315","author":"B Sun","year":"2025","unstructured":"Sun, B. et al. Charge regulated pH\/NIR dual responsive nanoplatforms centered on cuproptosis for enhanced cancer theranostics. Biomaterials 315, 122907 (2025).","journal-title":"Biomaterials"},{"key":"75509_CR46","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.1080\/10408398.2021.1913400","volume":"62","author":"MN Islam","year":"2022","unstructured":"Islam, M. N. et al. Superoxide dismutase: an updated review on its health benefits and industrial applications. Crit. Rev. Food Sci. Nutr. 62, 7282\u20137300 (2022).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"75509_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15373","volume":"526","author":"CM Hu","year":"2015","unstructured":"Hu, C. M. et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526, 118\u2013121 (2015).","journal-title":"Nature"},{"key":"75509_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304123","volume":"35","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. M2 macrophage hybrid membrane-camouflaged targeted biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy. Adv. Mater. 35, e2304123 (2023).","journal-title":"Adv. Mater."},{"key":"75509_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nature06421","volume":"450","author":"MA Sanjuan","year":"2007","unstructured":"Sanjuan, M. A. et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253\u20131257 (2007).","journal-title":"Nature"},{"key":"75509_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46210-1","volume":"15","author":"Y Xue","year":"2024","unstructured":"Xue, Y., Yan, X., Li, D., Dong, S. & Ping, Y. Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy. Nat. Commun. 15, 2270 (2024).","journal-title":"Nat. Commun."},{"key":"75509_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41392-025-02355-z","volume":"10","author":"R Guo","year":"2025","unstructured":"Guo, R. et al. Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment. Signal Transduct. Target. Ther. 10, 278 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75509_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107177","volume":"34","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Biomembrane-functionalized micromotors: biocompatible active devices for diverse biomedical applications. Adv. Mater. 34, e2107177 (2022).","journal-title":"Adv. Mater."},{"key":"75509_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41392-023-01560-y","volume":"8","author":"C Cheng","year":"2023","unstructured":"Cheng, C. et al. NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. Signal Transduct. Target. Ther. 8, 290 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75509_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41580-023-00645-4","volume":"25","author":"B Halliwell","year":"2024","unstructured":"Halliwell, B. Understanding mechanisms of antioxidant action in health and disease. Nat. Rev. Mol. Cell Biol. 25, 13\u201333 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75509_CR55","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1007\/s00253-019-09848-2","volume":"103","author":"N Nantapong","year":"2019","unstructured":"Nantapong, N. et al. The effect of reactive oxygen species (ROS) and ROS-scavenging enzymes, superoxide dismutase and catalase, on the thermotolerant ability of Corynebacterium glutamicum. Appl. Microbiol. Biotechnol. 103, 5355\u20135366 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"75509_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat. Commun. 13, 3432 (2022).","journal-title":"Nat. Commun."},{"key":"75509_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.123.323223","volume":"134","author":"JJ Lv","year":"2024","unstructured":"Lv, J. J. et al. CD147 sparks atherosclerosis by driving M1 phenotype and impairing efferocytosis. Circ. Res. 134, 165\u2013185 (2024).","journal-title":"Circ. Res."},{"key":"75509_CR58","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/CIRCRESAHA.123.324011","volume":"134","author":"P Kumar Jha","year":"2024","unstructured":"Kumar Jha, P., Aikawa, M. & Aikawa, E. Macrophage heterogeneity and efferocytosis: beyond the M1\/M2 dichotomy. Circ. Res. 134, 186\u2013188 (2024).","journal-title":"Circ. Res."},{"key":"75509_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308377","volume":"36","author":"ST Chuang","year":"2024","unstructured":"Chuang, S. T. et al. Enhancing CAR macrophage efferocytosis via surface engineered lipid nanoparticles targeting LXR signaling. Adv. Mater. 36, e2308377 (2024).","journal-title":"Adv. Mater."},{"key":"75509_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj3289","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis. Sci. Adv. 10, eadj3289 (2024).","journal-title":"Sci. Adv."},{"key":"75509_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202402968","volume":"36","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Activating macrophage continual efferocytosis via microenvironment biomimetic short fibers for reversing inflammation in bone repair. Adv. Mater. 36, e2402968 (2024).","journal-title":"Adv. Mater."},{"key":"75509_CR62","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","volume":"6","author":"SR Sukka","year":"2024","unstructured":"Sukka, S. R. et al. Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat. Metab. 6, 1736\u20131755 (2024).","journal-title":"Nat. Metab."},{"key":"75509_CR63","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai, B. et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc. Natl. Acad. Sci. USA 113, 6526\u20136531 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75509_CR64","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","volume":"119","author":"FC McGillicuddy","year":"2009","unstructured":"McGillicuddy, F. C. et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 119, 1135\u20131145 (2009).","journal-title":"Circulation"},{"key":"75509_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.715211","volume":"9","author":"E Opoku","year":"2021","unstructured":"Opoku, E. et al. Gasdermin D mediates inflammation-induced defects in reverse cholesterol transport and promotes atherosclerosis. Front. Cell Dev. Biol. 9, 715211 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"75509_CR66","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","volume":"115","author":"P Lewis","year":"2007","unstructured":"Lewis, P. et al. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115, 2178\u20132187 (2007).","journal-title":"Circulation"},{"key":"75509_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2021.02.025","volume":"518","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. The ABCA1-efferocytosis axis: a new strategy to protect against atherosclerosis. Clin. Chim. Acta 518, 1\u20138 (2021).","journal-title":"Clin. Chim. Acta"},{"key":"75509_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/pr.119.017897","volume":"72","author":"S Frambach","year":"2020","unstructured":"Frambach, S. et al. Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment. Pharmacol. Rev. 72, 152\u2013190 (2020).","journal-title":"Pharmacol. Rev."},{"key":"75509_CR69","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCRESAHA.110.217281","volume":"106","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet, L. et al. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ. Res. 106, 1861\u20131869 (2010).","journal-title":"Circ. Res."},{"key":"75509_CR70","doi-asserted-by":"publisher","first-page":"17881","DOI":"10.1021\/jacs.3c04981","volume":"145","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Rational design of a double-locked photoacoustic probe for precise in vivo imaging of cathepsin B in atherosclerotic plaques. J. Am. Chem. Soc. 145, 17881\u201317891 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"75509_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202411840","volume":"63","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Simultaneous in vivo imaging of neutrophil elastase and oxidative stress in atherosclerotic plaques using a unimolecular photoacoustic probe. Angew. Chem. Int. Ed. 63, e202411840 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75509_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64633-2","volume":"16","author":"H Cao","year":"2025","unstructured":"Cao, H. et al. Neutrophil elastase-activatable ratiometric photoacoustic nanoprobes for imaging atherosclerotic plaque vulnerability. Nat. Commun. 16, 9635 (2025).","journal-title":"Nat. Commun."},{"key":"75509_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02657-z","volume":"9","author":"W Gao","year":"2018","unstructured":"Gao, W. et al. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis. Nat. Commun. 9, 231 (2018).","journal-title":"Nat. Commun."},{"key":"75509_CR74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","volume":"15","author":"AM Flores","year":"2020","unstructured":"Flores, A. M. et al. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat. Nanotechnol. 15, 154\u2013161 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"75509_CR75","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12951-022-01720-2","volume":"20","author":"X Sha","year":"2022","unstructured":"Sha, X. et al. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect. J. Nanobiotechnol. 20, 506 (2022).","journal-title":"J. Nanobiotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75509-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:02:50Z","timestamp":1787702570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75509-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75509"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75509-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8996"}}